EloyEnriqueOrdaya EspinozaMD

PubMed

• 5 citations
  Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19).
  Jeremey Walker, Todd McCarty, Gerald McGwin, Eloy E Ordaya, Paschalis Vergidis
  Clinical Infectious Diseases. 2024-02-17
• 1 citations
  Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011-2021.
  Eloy E Ordaya, Omar M Abu Saleh, Paschalis Vergidis, Sharon M Deml, Nancy L Wengenack
  Mycoses. 2024-01-01
• 13 citations
  The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective.
  Eloy E Ordaya, Josh Clement, Paschalis Vergidis
  Mycopathologia. 2023-12-01

Journal Articles

• Cardiovascular involvement during the acute phase of Carrion's disease or human Bartonellosis: a 20-year experience in Cayetano Heredia National Hospital  
  Maguiña Vargas Ciro, Ordaya Espinoza Eloy, Ugarte-Gil Cesar, Franco Reusche Veronica, Ventosilla Lopez Palmira, Huayanay Falconí Leandro, Salazar Caceres Martín, Medin..., Acta méd. peruana. 2008; 25( 1 ): 30-38, 3/2008
• Update of Carrion's disease  
  Maguiña Vargas Ciro, Ugarte-Gil César, Breña Chávez Patricia, Ordaya Espinoza Eloy, Ventosilla López Palmira, Huarcaya Castilla Erick, Henriquez Camacho Cesar, Rev Med Hered. 2008; 19( 1 ): 36-41, 1/2008

Abstracts/Posters

• Clinical Characteristics and Correlation between Epidemiological Cut-off Values (ECV) and Mortality in Patients with Cryptococcosis
  Ordaya E, Abu Saleh O, Vergidis P, Hata J, Graf E, Wengenack N, Fida M., 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark, 4/2023
• Real-world Safety and Efficacy of Tixagevimab-Cilgavimab Pre-exposure Prophylaxis in Orthotopic Heart Transplant Recipients
  Ordaya EE, Higgins EM, Vergidis P, Razonable RR, Beam E., 4th Symposium on Infectious Diseases in the Immunocompromised Host - Fred Hutch Cancer Center, Seattle, Washington, 4/2023
• Decoding a Decade: Temporal Trends of MIC Distribution of Antifungals Against Cryptococcus species From a Reference Laboratory
  Ordaya EE, Abu Saleh OM, Vergidis P, Deml S, Wengenack N, Fida M., Open Forum Infect Dis. 2022 Dec 15;9(Suppl 2):ofac492.036, 12/9/2022
• Transplantation and Immigration: Comparing Infectious Complications Between Foreign-born vs. U.S.-born Kidney Transplant Recipients in Minnesota
  Eloy E Ordaya Espinoza, Megan Shaughnessy, Patricia F Walker, Rachel Husmann, Gabriel Hale, Jacob Stauffer, William Stauffer, III, Open Forum Infect Dis. 2020 Oct; 7(Suppl 1): S584, 12/31/2020
• Impact of Fungal Serologies in the Management of Veteran Patients with Suspected Endemic Mycoses
  Eloy E Ordaya, Dimitri M Drekonja, Open Forum Infect Dis. 2019 Oct; 6(Suppl 2): S151, 10/23/2019
• Correlation between Cytomegalovirus Breakthrough Disease in High Risk Solid Organ Transplant Recipients and ValganciclovirDose Modification
  Juan Lemos-Ramirez, Odaliz Abreu-Lanfranco, Ramon Del Busto, Mayur Ramesh, Jonathan Williams, Pallavi Bhargava, Eloy Ordaya, George Alangaden, Open Forum Infect Dis. 2017 Oct; 4 (Suppl 1):S519, 10/4/2017
• Novel T2 Magnetic Resonance Assay Compared to Standard Blood Cultures for Detection of Candidemia
  Shamik Dwivedi, Eloy Ordaya, Brie Kezlarian, Rachel Kenny, Robert Tibbetts, Linoj Samuel, George Alangaden, Open Forum Infect Dis. 2016 Oct; 3 (Suppl 1); S1571, 10/25/2016
• Join now to see all